Mayinglong Pharmaceutical Group Co., Ltd. (SHSE: 600993)
Health Care · Pharmaceuticals · CN
CN¥22.95
+1.91% today · -17.5% 1Y
Mayinglong Pharmaceutical Group Co., Ltd. (SHSE: 600993) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.48B and employs 2,544 people.
Over the last twelve months the share price has lost 17.5%, trading between 21.22 and 30.18.
Tweenvest scores Mayinglong Pharmaceutical Group Co., Ltd. across four factors: quality 84/100, value 81/100, growth 49/100, dividend 46/100. Its strongest factor is quality.
600993 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.48B
- Revenue (TTM)
- $578.45M
- P/E
- 16.50
- EPS
- 1.39
- Dividend yield
- 3.05%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥30.18
- 52-week low
- CN¥21.22
- Avg volume (3M)
- —
- Shares outstanding
- 431.05M
- Employees
- 2,544
- Next earnings
- —
About Mayinglong Pharmaceutical Group Co., Ltd.
Mayinglong Pharmaceutical Group Co., LTD. is a prominent Chinese entity primarily engaged in the manufacturing, wholesale, and retail of a diverse array of pharmaceutical products. Its extensive offerings encompass treatments for hemorrhoid, gynecological, cough, and skin conditions, alongside functional foods, traditional Chinese medicine drink tablets, and various medical devices. The company also facilitates sales through online channels. Expanding its operations, it additionally manages and runs its own hospitals. Headquartered in Wuhan, China, Mayinglong Pharmaceutical Group Co., LTD. possesses a rich history, having been founded in 1582.
- ISIN
- CNE000001HN2
- Founded
- 1582
- Listed since
- May 17, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Maze Therapeutics, Inc.NasdaqGM: MAZE | $1.51B | $27.11 | +2.57% |
| Yifan Pharmaceutical Co., Ltd.SZSE: 002019 | $1.50B | CN¥9.66 | +2.55% |
| Tianjin Chase Sun Pharmaceutical Co.,LtdSZSE: 300026 | $1.49B | CN¥3.32 | +2.15% |
| Jiangxi Fushine Pharmaceutical Co., Ltd.SZSE: 300497 | $1.48B | CN¥18.43 | +3.19% |
| Concord Biotech LimitedNSEI: CONCORDBIO | $1.47B | Rs1,361.40 | -0.92% |
| Rapport Therapeutics, Inc.NasdaqGM: RAPP | $1.47B | $30.65 | -4.72% |
| Zhejiang Hisoar Pharmaceutical Co., Ltd.SZSE: 002099 | $1.46B | CN¥6.32 | +2.76% |
| NATCO Pharma LimitedNSEI: NATCOPHARM | $1.46B | Rs789.40 | -3.88% |
Figures last refreshed Oct 11, 2026.